CKH Food & Health Limited - Asset Resilience Ratio
CKH Food & Health Limited (900120) has an Asset Resilience Ratio of 40.41% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how CKH Food & Health Limited's Asset Resilience Ratio has changed over time. Check 900120 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down CKH Food & Health Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CKH Food & Health Limited market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩1.03 Billion | 40.41% |
| Short-term Investments | ₩0.00 | 0% |
| Total Liquid Assets | ₩1.03 Billion | 40.41% |
Asset Resilience Insights
- Very High Liquidity: CKH Food & Health Limited maintains exceptional liquid asset reserves at 40.41% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
CKH Food & Health Limited Industry Peers by Asset Resilience Ratio
Compare CKH Food & Health Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621 |
Drug Manufacturers - Specialty & Generic | 2.04% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
|
Jw Pharmac
KO:001060 |
Drug Manufacturers - Specialty & Generic | 3.65% |
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Samjin Pharm
KO:005500 |
Drug Manufacturers - Specialty & Generic | 0.25% |
Annual Asset Resilience Ratio for CKH Food & Health Limited (2016–2023)
The table below shows the annual Asset Resilience Ratio data for CKH Food & Health Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 22.74% | ₩522.47 Million ≈ $354.07K |
₩2.30 Billion ≈ $1.56 Million |
+7.39pp |
| 2022-06-30 | 15.35% | ₩340.71 Million ≈ $230.89K |
₩2.22 Billion ≈ $1.50 Million |
+8.64pp |
| 2021-06-30 | 6.70% | ₩147.58 Million ≈ $100.01K |
₩2.20 Billion ≈ $1.49 Million |
-52.55pp |
| 2020-06-30 | 59.26% | ₩1.26 Billion ≈ $856.20K |
₩2.13 Billion ≈ $1.44 Million |
-11.39pp |
| 2017-06-30 | 70.65% | ₩2.55 Billion ≈ $1.73 Million |
₩3.61 Billion ≈ $2.45 Million |
+9.79pp |
| 2016-06-30 | 60.86% | ₩2.22 Billion ≈ $1.50 Million |
₩3.64 Billion ≈ $2.47 Million |
-- |
About CKH Food & Health Limited
CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It provides Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 a… Read more